Innoplexus is a leading global AI company in drug discovery and development with over 250 employees, 100+ patent applications, and 34 granted patents in artificial intelligence, machine learning and blockchain technologies. Innoplexus’ solutions can generate real-time insights from hundreds of terabytes of structured and unstructured proprietary and public data, thereby facilitating continuous informed decision-making for its customers at an unprecedented speed. Founded in 2015, Innoplexus AG is headquartered in Eschborn, Germany, with offices in Pune, India, as well as Iselin and San Francisco, United States.
It is the ambition of our drug discovery team to rapidly discover innovative therapeutic molecules with superior properties and better chances of success in multiple therapeutic areas. We develop and apply computational methods including multi-scale molecular simulations, bioinformatics, and AI to optimize small and large molecules.